OKE
62
-2
PRU
50
2
TXN
33
3
SCHW
49
3
OXY
41
4
ZTS
49
20
NWL
32
4
NOV
37
-2
FLS
50
-3
FIS
50
-3
INTU
69
4
CB
58
-2
EQT
19
-5
CAG
39
5
FLR
36
-3
WRK
60
-3
NTRS
39
2
IPG
42
-2
UNP
50
4
GIS
54
2
OKE
62
-2
PRU
50
2
TXN
33
3
SCHW
49
3
OXY
41
4
ZTS
49
20
NWL
32
4
NOV
37
-2
FLS
50
-3
FIS
50
-3
INTU
69
4
CB
58
-2
EQT
19
-5
CAG
39
5
FLR
36
-3
WRK
60
-3
NTRS
39
2
IPG
42
-2
UNP
50
4
GIS
54
2
Financhill
Back

Edgewise Therapeutics Stock Predictions

Buy
53

EWTX
Edgewise Therapeutics

Last Price:
16.72
Seasonality Move:
-4.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Edgewise Therapeutics Stock Forecast

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 19.9% based on the past 3 years of stock performance.
  • Edgewise Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Edgewise Therapeutics Stock Undervalued?
    The current Edgewise Therapeutics [EWTX] share price is $17.05. The Score for EWTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Edgewise Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 19.9% based on the past 3 years of stock performance.

Edgewise Therapeutics Stock Rating

Buy
53
Edgewise Therapeutics (EWTX) is a Buy

Is Edgewise Therapeutics overpriced?

  • Edgewise Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Edgewise Therapeutics Stock Price History

Is EWTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com

52-Week Data

52-Week High:
21.60
52-Week Low:
5.12

Prediction Charts

Market Cap:
1.59B
Price in USD:
17.05
Volume:
757.24K
Beta:
0.13

Technical Analysis

SMA50:
17.50
SMA100:
17.49
SMA200:
12.68
52-Wk Change:
113.93%

Stock Predictions

  • Is Edgewise Therapeutics stock public?
    Yes, Edgewise Therapeutics is a publicly traded company.
  • What is the Edgewise Therapeutics stock quote today?
    The Edgewise Therapeutics stock price is 17.05 USD today.
  • How to buy Edgewise Therapeutics stock online?
    You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-3 17.41 17.39 17.99 17.00
Jun-4 17.43 17.44 17.56 16.89
Jun-5 17.58 18.01 18.16 17.36
Jun-6 17.96 17.61 18.44 17.55
Jun-7 17.36 17.66 17.96 17.15
Jun-10 17.45 17.13 17.74 16.96
Jun-11 16.80 17.10 17.18 16.50
Jun-12 17.70 17.87 18.17 17.20
Jun-13 17.80 17.89 18.13 17.55
Jun-14 17.62 17.51 18.00 17.20
Jun-17 17.46 17.37 17.72 17.13
Jun-18 17.27 16.18 17.27 15.87
Jun-20 16.04 16.80 17.14 16.04
Jun-21 17.02 17.05 17.76 17.01

Edgewise Therapeutics Earnings

Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Edgewise Therapeutics Forecast Revenue Growth

Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.39 per share.

* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.